X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (1207) 1207
lenalidomide (1171) 1171
humans (1081) 1081
multiple myeloma (929) 929
hematology (887) 887
oncology (806) 806
bortezomib (640) 640
multiple myeloma - drug therapy (541) 541
stem-cell transplantation (478) 478
male (442) 442
aged (437) 437
female (436) 436
thalidomide (430) 430
thalidomide - analogs & derivatives (419) 419
dexamethasone (399) 399
middle aged (394) 394
antineoplastic combined chemotherapy protocols - therapeutic use (369) 369
treatment outcome (356) 356
transplantation (334) 334
therapy (325) 325
multiple myeloma - therapy (286) 286
care and treatment (280) 280
survival (279) 279
chemotherapy (271) 271
adult (269) 269
antineoplastic agents - therapeutic use (262) 262
lenalidomide plus dexamethasone (261) 261
thalidomide - administration & dosage (261) 261
thalidomide - therapeutic use (251) 251
cancer (242) 242
stem cells (226) 226
multiple myeloma - mortality (207) 207
maintenance (201) 201
hematology, oncology and palliative medicine (188) 188
elderly-patients (180) 180
open-label (177) 177
aged, 80 and over (171) 171
multiple myeloma - pathology (171) 171
drug therapy (170) 170
medicine & public health (162) 162
stem cell transplantation (160) 160
multiple myeloma - diagnosis (156) 156
disease-free survival (154) 154
dexamethasone - administration & dosage (153) 153
transplantation, autologous (150) 150
patients (148) 148
prognosis (148) 148
thalidomide - adverse effects (148) 148
antineoplastic combined chemotherapy protocols - adverse effects (147) 147
trial (142) 142
recurrence (141) 141
melphalan (140) 140
autologous transplantation (139) 139
research (134) 134
combination (131) 131
multiple-myeloma (129) 129
analysis (128) 128
myeloma (128) 128
pharmacology & pharmacy (125) 125
immunologic factors - therapeutic use (122) 122
prednisone (122) 122
immunology (120) 120
hematopoietic stem cell transplantation (119) 119
plus dexamethasone (119) 119
carfilzomib (118) 118
lenalidomide maintenance (114) 114
clinical trials (110) 110
cyclophosphamide (109) 109
retrospective studies (109) 109
low-dose dexamethasone (108) 108
article (107) 107
health aspects (106) 106
survival analysis (106) 106
maintenance therapy (105) 105
clinical trials as topic (101) 101
combination therapy (101) 101
pomalidomide (98) 98
rituximab (98) 98
patient outcomes (93) 93
relapse (93) 93
antineoplastic agents - adverse effects (92) 92
angiogenesis inhibitors (91) 91
boronic acids - administration & dosage (90) 90
pyrazines - administration & dosage (90) 90
lymphomas (87) 87
autografts (86) 86
leukemia (86) 86
diagnosis (84) 84
survival rate (83) 83
antineoplastic combined chemotherapy protocols - administration & dosage (82) 82
dosage and administration (82) 82
hemic and lymphatic diseases (82) 82
antineoplastic agents - administration & dosage (81) 81
risk factors (81) 81
hematopoietic stem cell transplantation - methods (80) 80
combined modality therapy (79) 79
minimal residual disease (78) 78
multicenter (78) 78
remission induction (78) 78
review (78) 78
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (1564) 1564
German (21) 21
French (5) 5
Polish (4) 4
Korean (2) 2
Russian (2) 2
Hungarian (1) 1
Japanese (1) 1
Slovak (1) 1
Spanish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The New England Journal of Medicine, ISSN 0028-4793, 09/2014, Volume 371, Issue 10, pp. 895 - 905
In patients 65 or younger with multiple myeloma, high-dose consolidation therapy was associated with longer survival and more myelotoxicity than... 
MEDICINE, GENERAL & INTERNAL | PREDNISONE | PLUS DEXAMETHASONE | INDUCTION THERAPY | LENALIDOMIDE | INITIAL TREATMENT | RANDOMIZED CONTROLLED-TRIAL | BORTEZOMIB | STEM-CELL TRANSPLANTATION | ELDERLY-PATIENTS | MELPHALAN | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Multiple Myeloma - mortality | Humans | Middle Aged | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Transplantation, Autologous | Consolidation Chemotherapy | Antineoplastic Agents, Alkylating - administration & dosage | Thalidomide - analogs & derivatives | Multiple Myeloma - drug therapy | Multiple Myeloma - therapy | Melphalan - adverse effects | Adult | Maintenance Chemotherapy | Neutropenia - chemically induced | Thalidomide - adverse effects | Prednisone - administration & dosage | Prednisone - adverse effects | Kaplan-Meier Estimate | Combined Modality Therapy | Thalidomide - administration & dosage | Disease-Free Survival | Melphalan - administration & dosage | Aged | Antineoplastic Agents, Alkylating - adverse effects | Stem Cell Transplantation - adverse effects | Complications and side effects | Care and treatment | Patient outcomes | Multiple myeloma | Stem cells | Transplantation | Research | Health aspects | Autografts | Chemotherapy | Cell survival | Transplants & implants | Melphalan | Stem cell transplantation | Death | Prednisone | Drug dosages | Neutropenia | Index Medicus | Abridged Index Medicus
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 08/2012, Volume 30, Issue 24, pp. 2946 - 2955
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 09/2017, Volume 35, Issue 25, pp. 2911 - 2918
Journal Article
Blood, ISSN 0006-4971, 03/2012, Volume 119, Issue 13, pp. 3003 - 3015
Journal Article
Journal Article
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, ISSN 0732-183X, 10/2017, Volume 35, Issue 29, pp. 3279 - 3289
Journal Article
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2015, Volume 16, Issue 13, pp. 1370 - 1379
Journal Article
by Dimopoulos, Meletios A and Gay, Francesca and Schjesvold, Fredrik and Beksac, Meral and Hajek, Roman and Weisel, Katja Christina and Goldschmidt, Hartmut and Maisnar, Vladimir and Moreau, Philippe and Min, Chang Ki and Pluta, Agnieszka and Chng, Wee-Joo and Kaiser, Martin and Zweegman, Sonja and Mateos, Maria-Victoria and Spencer, Andrew and Iida, Shinsuke and Morgan, Gareth and Suryanarayan, Kaveri and Teng, Zhaoyang and Skacel, Tomas and Palumbo, Antonio and Dash, Ajeeta B and Gupta, Neeraj and Labotka, Richard and Rajkumar, S Vincent and Bar, Daniel and Basso, Alfredo and Fantl, Dorotea and He, Simon and Horvath, Neomi and Lee, Cindy and Rowlings, Phillip and Taylor, Kerry and Spencer, Andrew and Cochrane, Tara and Kwok, Fiona and Ramanathan, Sundreswran and Agis, Hermine and Zojer, Niklas and Kentos, Alain and Offner, Fritz and Van Droogenbroeck, Jan and Wu, Ka Lung and Maiolino, Angelo and Martinez, Gracia and Zanella, Karla and Capra, Marcelo and Araújo, Sérgio and Gregora, Evzen and Hajek, Roman and Maisnar, Vladimir and Pour, Ludek and Scudla, Vlastimil and Spicka, Ivan and Abildgaard, Niels and Andersen, Niels and Jensen, Bo Amdi and Helleberg, Carsten and Plesner, Torben and Salomo, Morten and Svirskaite, Asta and Delarue, Richard and Moreau, Philippe and Blau, Igor and Goldschmidt, Hartmut and Schieferdecker, Aneta and Teleanu, Veronica and Munder, Markus and Röllig, Christoph and Salwender, Han-Juergen and Fuhrmann, Stephan and Weisel, Katja and Duerig, Jan and Zeis, Matthias and Klein, Stefan and Reimer, Peter and Schmidt, Christian and Scheid, Christof and Mayer, Karin and Hoffmann, Martin and Sosada, Markus and Dimopoulos, Athanasios and Delimpasi, Sosana and Kyrtsonis, Mary-Christine and Anagnostopoulos, Achilleas and Nagy, Zsolt and Illés, Árpád and Egyed, Miklós and Borbényi, Zita and Mikala, Gabor and Dally, Najib and Horowitz, Netanel and Gutwein, Odit and Nemets, Anatoly and Vaxman, Iuliana and Shvetz, Olga and Trestman, Svetlana and Ruchlemer, Rosa and Nagler, Arnon and ... and TOURMALINE-MM3 study group and TOURMALINE-MM3 Study Grp
The Lancet, ISSN 0140-6736, 01/2019, Volume 393, Issue 10168, pp. 253 - 264
Journal Article
Annals of Oncology, ISSN 0923-7534, 08/2019, Volume 30, Issue 8, pp. 1397 - 1398
Journal Article
Clinical Therapeutics, ISSN 0149-2918, 07/2018, Volume 40, Issue 7, pp. 1193 - 1202.e1
Journal Article